PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$8.36
Tradestie Score
50
Market Cap
$871.90M
Revenue Growth
0.9%
Analyst Upside
+157.2%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$17.01
|
$726.21M | 16.4 | 43 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$25.10
|
$718.62M | - | 60 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$22.03
|
$715.25M | - | 35 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$150.13
|
$699.30M | - | 54 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.73
|
$688.47M | - | 43 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ARVN
Arvinas, Inc
|
$8.45
|
$670.30M | 33.5 | 33 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.79
|
$665.30M | 14.8 | 41 | Compare |
|
MPLT
MPLT
|
$13.00
|
$639.32M | - | 31 | Compare |
More PHAT Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry